NASDAQ:CASI   CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. (CASI) is still in bottoming mode. The technical indicators are looking better now for the stock. The MACD is starting to rise, confirming a bullish divergence has taken form and the Stochastic also has a bullish crossover. It might attempt to breakout above the $1.25 level on Monday and if it succeeds we should expect a strong move to the upside. It has the potential to make another big run next week, so keep a close eye on CASI and don’t miss the trade. The price target of the two Wall Street analysts that rated the stock since the last quarterly report is $3.9

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.